MedPath

A Single Patient IND for PD-0325901

Conditions
Prior Treatment With PD-0325901 With Ongoing Clinical Response
Registration Number
NCT02297802
Lead Sponsor
Sharp HealthCare
Brief Summary

The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
NO_LONGER_AVAILABLE
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Prior treatment with PD-0325901 with ongoing response
Exclusion Criteria
  • none

Study & Design

Study Type
EXPANDED_ACCESS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sharp Healthcare

🇺🇸

San Diego, California, United States

Sharp Healthcare
🇺🇸San Diego, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.